JP2019519466A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519466A5 JP2019519466A5 JP2018548761A JP2018548761A JP2019519466A5 JP 2019519466 A5 JP2019519466 A5 JP 2019519466A5 JP 2018548761 A JP2018548761 A JP 2018548761A JP 2018548761 A JP2018548761 A JP 2018548761A JP 2019519466 A5 JP2019519466 A5 JP 2019519466A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- asp
- lys
- represented
- met
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 claims 17
- 108090000623 proteins and genes Proteins 0.000 claims 17
- 102000003966 Alpha-1-microglobulin Human genes 0.000 claims 15
- 101800001761 Alpha-1-microglobulin Proteins 0.000 claims 15
- 230000002950 deficient Effects 0.000 claims 9
- 230000007547 defect Effects 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000037430 deletion Effects 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 230000003796 beauty Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 101100002951 Caenorhabditis elegans asp-17 gene Proteins 0.000 claims 1
- 101100338278 Caenorhabditis elegans his-66 gene Proteins 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 150000003278 haem Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201670158 | 2016-03-18 | ||
| DKPA201670158 | 2016-03-18 | ||
| PCT/EP2017/056436 WO2017158181A1 (en) | 2016-03-18 | 2017-03-17 | Novel alpha-1-microglobulin derived proteins and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019519466A JP2019519466A (ja) | 2019-07-11 |
| JP2019519466A5 true JP2019519466A5 (enExample) | 2020-04-23 |
| JP6976579B2 JP6976579B2 (ja) | 2021-12-08 |
Family
ID=56080208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548761A Active JP6976579B2 (ja) | 2016-03-18 | 2017-03-17 | 新規アルファ−１−マイクログロブリン由来タンパク質ならびにそれらの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10981963B2 (enExample) |
| EP (1) | EP3430032B1 (enExample) |
| JP (1) | JP6976579B2 (enExample) |
| KR (1) | KR102437662B1 (enExample) |
| CN (1) | CN108779157B (enExample) |
| AU (1) | AU2017235608B2 (enExample) |
| BR (1) | BR112018068522A2 (enExample) |
| CA (1) | CA3017836A1 (enExample) |
| EA (1) | EA039776B1 (enExample) |
| ES (1) | ES2896734T3 (enExample) |
| MX (1) | MX2018011193A (enExample) |
| NZ (1) | NZ746677A (enExample) |
| SG (1) | SG11201807352XA (enExample) |
| WO (1) | WO2017158181A1 (enExample) |
| ZA (1) | ZA201805797B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111511386A (zh) * | 2017-11-03 | 2020-08-07 | 卫士医疗国际公司 | α-1-微球蛋白用于保护骨髓细胞的用途 |
| WO2024165674A1 (en) | 2023-02-08 | 2024-08-15 | Guard Therapeutics International AB | Alpha-1-microglobulin derived peptide fragments and uses thereof |
| US12227343B2 (en) * | 2023-03-17 | 2025-02-18 | Blue Buffalo Enterpises, Inc. | Retail ready opening feature for e-commerce carton |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2313106B1 (en) * | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
| WO2013113851A1 (en) * | 2012-01-31 | 2013-08-08 | Technische Universitaet Muenchen | Muteins of a1m lipocalin and method of production therefor |
| ES2599034T3 (es) * | 2012-09-05 | 2017-01-31 | A1M Pharma Ab | Alfa-1-microglobulina para su uso en el tratamiento de enfermedades relacionadas con mitocondrias |
| WO2014047490A1 (en) * | 2012-09-21 | 2014-03-27 | Beintoo, S.P.A. | Interactive experience fully contained within an expandalble embedded unit |
| US10226570B2 (en) * | 2017-03-10 | 2019-03-12 | Seton Healthcare Family | Apparatus and method for temporarily securing a movable accessory device relative to a movable patient |
-
2017
- 2017-03-17 BR BR112018068522A patent/BR112018068522A2/pt unknown
- 2017-03-17 MX MX2018011193A patent/MX2018011193A/es unknown
- 2017-03-17 SG SG11201807352XA patent/SG11201807352XA/en unknown
- 2017-03-17 US US16/085,500 patent/US10981963B2/en active Active
- 2017-03-17 WO PCT/EP2017/056436 patent/WO2017158181A1/en not_active Ceased
- 2017-03-17 KR KR1020187029939A patent/KR102437662B1/ko active Active
- 2017-03-17 AU AU2017235608A patent/AU2017235608B2/en active Active
- 2017-03-17 EP EP17711205.9A patent/EP3430032B1/en active Active
- 2017-03-17 ES ES17711205T patent/ES2896734T3/es active Active
- 2017-03-17 NZ NZ746677A patent/NZ746677A/en unknown
- 2017-03-17 CN CN201780018244.4A patent/CN108779157B/zh active Active
- 2017-03-17 CA CA3017836A patent/CA3017836A1/en active Pending
- 2017-03-17 EA EA201892085A patent/EA039776B1/ru unknown
- 2017-03-17 JP JP2018548761A patent/JP6976579B2/ja active Active
-
2018
- 2018-08-29 ZA ZA2018/05797A patent/ZA201805797B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533722A5 (enExample) | ||
| JP2020023567A5 (enExample) | ||
| JP2013533273A5 (enExample) | ||
| JP2018506286A5 (enExample) | ||
| IL262805B1 (en) | CD47 agonist factors for inducing programmed cell death and their use in the treatment of diseases associated with defects in programmed cell death | |
| JP2010500399A5 (enExample) | ||
| JP2018515088A5 (enExample) | ||
| HRP20201353T1 (hr) | Agonisti glukagonskog receptora | |
| JP2018522563A5 (enExample) | ||
| TW201613958A (en) | MIC-1 fusion proteins and uses thereof | |
| JP2012500001A5 (enExample) | ||
| JP2013515057A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2018538356A5 (enExample) | ||
| JP2015532307A5 (enExample) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2019510739A5 (enExample) | ||
| JP2015513527A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| RU2012136530A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2014529399A5 (enExample) | ||
| JP2019519466A5 (enExample) | ||
| JP2015513318A5 (enExample) |